Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

RPEP-136012025Sikiric, Predrag; Seiwerth, Sven; Skrtic, Anita; Staresinic, Mario; Strbe, Sanja; Vuksic, Antonia; Sikiric, Suncana; Bekic, Dinko; Soldo, Dragan; Grizelj, Boris; Novosel, Luka; Beketic Oreskovic, Lidija; Oreskovic, Ivana; Stupnisek, Mirjana; Boban Blagaic, Alenka; Dobric, Ivan

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

Pharmaceuticals (Basel, Switzerland), 18(6)

View on PubMed ↗Publisher’s paper ↗

Citation

Sikiric, Predrag; Seiwerth, Sven; Skrtic, Anita; Staresinic, Mario; Strbe, Sanja; Vuksic, Antonia; Sikiric, Suncana; Bekic, Dinko; Soldo, Dragan; Grizelj, Boris; Novosel, Luka; Beketic Oreskovic, Lidija; Oreskovic, Ivana; Stupnisek, Mirjana; Boban Blagaic, Alenka; Dobric, Ivan. (2025). Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.. Pharmaceuticals (Basel, Switzerland), 18(6). https://doi.org/10.3390/ph18060928